Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Sep;74(9):3903–3907. doi: 10.1073/pnas.74.9.3903

Synthesis of fibrinolytic activator and inhibitor by endothelial cells*

David J Loskutoff 1, Thomas S Edgington 1
PMCID: PMC431779  PMID: 143664

Abstract

Vascular endothelial cells derived from rabbit vena cava and maintained in continuous culture exhibited properties characteristic of the intact endothelium. These cells were used as a model for characterizing the fibrinolytic components specified by the endothelium. Endothelial cells in culture digested radiolabeled fibrinogen. Digestion resulted from the synthesis and secretion of a plasminogen activator. Fibrinolysis was not detected when cells were grown in medium lacking plasminogen, indicating the absence of plasminogen-independent fibrinolytic enzymes. Phorbol-myristate-acetate increased extracellular plasminogen activator activity dramatically. This increase was prevented when actinomycin D or cycloheximide was included in the growth medium, indicating that new gene expression was required for it. Intracellular plasminogen activator could not be detected unless the cell extracts were exposed briefly to mildly acidic conditions. Mixing experiments between acid-treated and untreated extracts suggested that the cells contained a potent, acid-labile inhibitor of fibrinolysis. As little as 10 μg of protein from whole cell extracts inhibited both cell and urokinase-mediated fibrinolysis by more than 70%. Cell fractionation studies localized the inhibitor to the cytosol whereas plasminogen activator activity was restricted to the membrane-rich fraction. This membrane fraction did not require acidification for activity, suggesting that the inhibitor had been removed and that acidification did not activate a plasminogen proactivator. These observations demonstrate that regulation of endothelial fibrinolytic activity is far more complex than had been anticipated and raise several uncertainties in regard to detecting the presence of plasminogen activators in cells and tissues.

Keywords: plasminogen activator, phorbol-myristate-acetate, cell culture

Full text

PDF
3903

Images in this article

3904Image
on p.3904

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALI S. Y., LACK C. H. STUDIES ON THE TISSUE ACTIVATOR OF PLASMINOGEN. DISTRIBUTION OF ACTIVATOR AND PROTEOLYTIC ACTIVITY IN THE SUBCELLULAR FRACTIONS OF RABBIT KIDNEY. Biochem J. 1965 Jul;96:63–74. doi: 10.1042/bj0960063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Astrup T., Thorsen S. The physiology of fibrinolysis. Med Clin North Am. 1972 Jan;56(1):153–162. doi: 10.1016/s0025-7125(16)32431-2. [DOI] [PubMed] [Google Scholar]
  3. Beers W. H., Strickland S., Reich E. Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell. 1975 Nov;6(3):387–394. doi: 10.1016/0092-8674(75)90188-9. [DOI] [PubMed] [Google Scholar]
  4. Belman S., Troll W. Phorbol-12-myristate-13-acetate effect on cyclic adenosine 3',5'-monophosphate levels in mouse skin and inhibition of phorbol-myristate-acetate-promoted tumorigenesis by theophylline. Cancer Res. 1974 Dec;34(12):3446–3455. [PubMed] [Google Scholar]
  5. Blumberg P. M., Driedger P. E., Rossow P. W. Effect of a phorbol ester on a transformation-sensitive surface protein of chick fibroblasts. Nature. 1976 Dec 2;264(5585):446–447. doi: 10.1038/264446a0. [DOI] [PubMed] [Google Scholar]
  6. Buonassisi V., Venter J. C. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc Natl Acad Sci U S A. 1976 May;73(5):1612–1616. doi: 10.1073/pnas.73.5.1612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Caldwell P. R., Seegal B. C., Hsu K. C., Das M., Soffer R. L. Angiotensin-converting enzyme: vascular endothelial localization. Science. 1976 Mar 12;191(4231):1050–1051. doi: 10.1126/science.175444. [DOI] [PubMed] [Google Scholar]
  8. Deutsch D. G., Mertz E. T. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970 Dec 4;170(3962):1095–1096. doi: 10.1126/science.170.3962.1095. [DOI] [PubMed] [Google Scholar]
  9. Florey The endothelial cell. Br Med J. 1966 Aug 27;2(5512):487–490. doi: 10.1136/bmj.2.5512.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gimbrone M. A., Jr, Alexander R. W. Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium. Science. 1975 Jul 18;189(4198):219–220. doi: 10.1126/science.1138377. [DOI] [PubMed] [Google Scholar]
  11. Gimbrone M. A., Jr Culture of vascular endothelium. Prog Hemost Thromb. 1976;3:1–28. [PubMed] [Google Scholar]
  12. Glas P., Astrup T. Thromboplastin and plasminogen activator in tissues of the rabbit. Am J Physiol. 1970 Oct;219(4):1140–1146. doi: 10.1152/ajplegacy.1970.219.4.1140. [DOI] [PubMed] [Google Scholar]
  13. Hecker E. Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae. Cancer Res. 1968 Nov;28(11):2338–2349. [PubMed] [Google Scholar]
  14. Hegt V. N., Brakman P. Histochemical study of an inhibitor of fibrinolysis in the human arterial wall. Nature. 1974 Mar 1;248(5443):75–76. doi: 10.1038/248075a0. [DOI] [PubMed] [Google Scholar]
  15. Hegt V. N. Localization and distribution of fibrinolysis inhibition in the walls of human arteries and veins. Thromb Res. 1977 Jan;10(1):121–133. doi: 10.1016/0049-3848(77)90085-8. [DOI] [PubMed] [Google Scholar]
  16. Isacson S. Effect of prednisolone on the coagulation and fibrinolytic systems. Scand J Haematol. 1970;7(3):212–216. doi: 10.1111/j.1600-0609.1970.tb01890.x. [DOI] [PubMed] [Google Scholar]
  17. Jaffe E. A., Hoyer L. W., Nachman R. L. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest. 1973 Nov;52(11):2757–2764. doi: 10.1172/JCI107471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jaffe E. A., Hoyer L. W., Nachman R. L. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci U S A. 1974 May;71(5):1906–1909. doi: 10.1073/pnas.71.5.1906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kwaan H. C. Tissue fibrinolytic activity studied by a histochemical method. Fed Proc. 1966 Jan-Feb;25(1):52–56. [PubMed] [Google Scholar]
  20. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  21. MOSESSON M. W. The preparation of human fibrinogen free of plasminogen. Biochim Biophys Acta. 1962 Feb 26;57:204–213. doi: 10.1016/0006-3002(62)91112-5. [DOI] [PubMed] [Google Scholar]
  22. McConahey P. J., Dixon F. J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966;29(2):185–189. doi: 10.1159/000229699. [DOI] [PubMed] [Google Scholar]
  23. McDonald R. I., Shepro D., Rosenthal M., Booyse F. M. Properties of cultured endothelial cells. Ser Haematol. 1973;6(4):469–478. [PubMed] [Google Scholar]
  24. Mott D. M., Fabisch P. H., Sani B. P., Sorof S. Lack of correlation between fibrinolysis and the transformed state of cultured mammalian cells. Biochem Biophys Res Commun. 1974 Nov 27;61(2):621–627. doi: 10.1016/0006-291x(74)91002-x. [DOI] [PubMed] [Google Scholar]
  25. Nolan C., Hall L. S., Barlow G. H., Tribby I. I. Plasminogen activator from human embryonic kidney cell cultures. Evidence for a proactivator. Biochim Biophys Acta. 1977 Feb 28;496(2):384–400. doi: 10.1016/0304-4165(77)90321-x. [DOI] [PubMed] [Google Scholar]
  26. Plow E. F., Edgington T. S. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. J Clin Invest. 1975 Jul;56(1):30–38. doi: 10.1172/JCI108076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pugatch E. M., Foster E. A., Macfarlane D. E., Poole J. C. The extraction and separation of activators and inhibitors of fibrinolysis from bovine endothelium and mesothelium. Br J Haematol. 1970 Jun;18(6):669–681. doi: 10.1111/j.1365-2141.1970.tb01592.x. [DOI] [PubMed] [Google Scholar]
  28. Quigley J. P. Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells. J Cell Biol. 1976 Nov;71(2):472–486. doi: 10.1083/jcb.71.2.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sheppard J. R. Restoration of contact-inhibited growth to transformed cells by dibutyryl adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1316–1320. doi: 10.1073/pnas.68.6.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. TODD A. S. The histological localisation of fibrinolysin activator. J Pathol Bacteriol. 1959 Jul;78:281–283. doi: 10.1002/path.1700780131. [DOI] [PubMed] [Google Scholar]
  31. Tagnon H. J., Palade G. E. ACTIVATION OF PROPLASMIN BY A FACTOR FROM MAMMALIAN TISSUE. J Clin Invest. 1950 Mar;29(3):317–324. doi: 10.1172/JCI102260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Unkeless J. C., Gordon S., Reich E. Secretion of plasminogen activator by stimulated macrophages. J Exp Med. 1974 Apr 1;139(4):834–850. doi: 10.1084/jem.139.4.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Unkeless J. C., Tobia A., Ossowski L., Quigley J. P., Rifkin D. B., Reich E. An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med. 1973 Jan 1;137(1):85–111. doi: 10.1084/jem.137.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vassalli J. D., Hamilton J., Reich E. Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell. 1976 Jun;8(2):271–281. doi: 10.1016/0092-8674(76)90011-8. [DOI] [PubMed] [Google Scholar]
  35. WARREN B. A. FIBRIONLYTIC ACTIVITY OF VASCULAR ENDOTHELIUM. Br Med Bull. 1964 Sep;20:213–214. doi: 10.1093/oxfordjournals.bmb.a070334. [DOI] [PubMed] [Google Scholar]
  36. Wigler M., Weinstein I. B. Tumour promotor induces plasminogen activator. Nature. 1976 Jan 22;259(5540):232–233. doi: 10.1038/259232a0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES